What every Hepatologist should Know about Swine Flu?

Authors:

Lankarani KB
Health Policy Research Center and Gastroenterogy and Hepatology Research Center, Shiraz University of Medical Sciences, Shiraz, I.R. Iran

Correspondence:

Kamran Bagheri Lankarani, M.D.
Department: Health Policy Research Center and Gastroenterogy and Hepatology Research Center, Shiraz University of Medical Sciences
City: Shiraz
Country: I.R. Iran
E-mail: lankaran@sums.ac.ir

References:

1.  Schout D, Hajjar LA, Galas FR, et al. Epidemiology of human infection with the novel virus influenza A (H1N1) in the Hospital das Clinicas, Sao Paulo, Brazil--June-September 2009. Clinics (Sao Paulo). 2009;64(10):1025-30. [PubMed]

2.  Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14(33). [PubMed]

3.  Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009;58(27):749-52. [PubMed]

4.  Davis LE, Kornfeld M. Mouse influenza B virus model of Reye's syndrome. Encephalopathy and microvesicular fatty metamorphosis of the liver by influenza B virus following intravenous administration in mice. Am J Pathol. 1986;122(1):190-2. [PubMed]

5.  Adams DH, Hubscher SG. Systemic viral infections and collateral damage in the liver. Am J Pathol. 2006;168(4):1057-9. [PubMed]

6.  Fislova T, Gocnik M, Sladkova T, et al. Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch Virol. 2009;154(3):409-19. [PubMed]

7.  Woodfin BM, Kazim AL. Interaction of the amino-terminus of an influenza virus protein with mitochondria. Arch Biochem Biophys. 1993;306(2):427-30. [PubMed]

8.  Polakos NK, Cornejo JC, Murray DA, et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol. 2006;168(4):1169-78; quiz 404-5. [PubMed]

9.  Monto AS. The disappearance of Reye's syndrome--a public health triumph. N Engl J Med. 1999;340(18):1423-4. [PubMed]

10.  Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340(18):1377-82. [PubMed]

11.  Wood LE, Tulloh RM. Kawasaki disease in children. Heart. 2009;95(10):787-92. [PubMed]

12.  Stanley TV. Acute liver failure following influenza B infection. N Z Med J. 1994;107(986 Pt 1):382. [PubMed]

13.  Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection in patients before and after liver transplantation. Liver Transpl. 2000;6(5):531-42. [PubMed]

14.  Planas R, Balleste B, Alvarez MA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol. 2004;40(5):823-30. [PubMed]

15.  Cheruvattath R, Balan V. Infections in Patients With End-stage Liver Disease. J Clin Gastroenterol. 2007;41(4):403-11. [PubMed]

16.  Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11(6):954-63. [PubMed]

17.  Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009;9(8):493-504. [PubMed]

18.  Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis. 1996;22(2):295-302. [PubMed]

19.  Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl. 2001;7(4):311-3. [PubMed]

20.  Ljungman P, Andersson J, Aschan J, et al. Influenza A in immunocompromised patients. Clin Infect Dis. 1993;17(2):244-7. [PubMed]

21.  Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 2000;61(1):85-93. [PubMed]

22.  Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med. 2009. [PubMed]

23.  Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302(17):1896-902. [PubMed]

24.  Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis. 1998;178(5):1257-62. [PubMed]

25.  Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB. Influenza vaccine antibody responses in lung transplant recipients. Prog Transplant. 2004;14(4):346-51. [PubMed]

26.  Smith KG, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant. 1998;13(1):160-4. [PubMed]

27.  Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant. 2004;4 Suppl 10:160-3. [PubMed]

28.  Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Mauer JR. Cell-mediated immune response to influenza vaccination in lung transplant recipients. J Heart Lung Transplant. 2004;23(10):1175-81. [PubMed]

29.  White-Williams C, Brown R, Kirklin J, et al. Improving clinical practice: should we give influenza vaccinations to heart transplant patients? J Heart Lung Transplant. 2006;25(3):320-3. [PubMed]

30.  Chesi C, Gunther M, Huzly D, et al. Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic survey. Transpl Infect Dis. 2009. [PubMed]

31.  Hanania NA, Sockrider M, Castro M, et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004;113(4):717-24. [PubMed]

32.  Madan RP, Tan M, Fernandez-Sesma A, et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis. 2008;46(5):712-8. [PubMed]

33.  Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis. 2009;200(2):172-80. [PubMed]